version of the Guidelines, which is freely available via the ESC and EAS websites and
hosted on their journals' websites (EHJ and Atherosclerosis Journal). The National Cardiac …

Atherosclerotic cardiovascular disease (CVD) is a chronic disorder developing insidiously
throughout life and usually progressing to an advanced stage by the time symptoms occur. It …

2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …

5.1. Wpływ stylu życia na stężenie cholesterolu całkowitego i stężenie cholesterolu frakcji
lipoprotein o małej gęstości................................ 1259 5.2. Wpływ stylu życia na stężenie …

The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

Low-density lipoprotein (LDL) cholesterol concentration has been the prime index of
cardiovascular disease risk and the main target for therapy. However, several lipoprotein …

Background—Whether apolipoprotein B (apoB) or non-high-density lipoprotein cholesterol
(HDL-C) adds to the predictive power of low-density lipoprotein cholesterol (LDL-C) for …

Hypertriglyceridemia is a prevalent risk factor for cardiovascular disease (CVD) and
increasingly important in the setting of current obesity and insulin resistance epidemics …

Background—Lipid profiles are usually measured after fasting. We tested the hypotheses
that these levels change only minimally in response to normal food intake and that …

During the last several years interest has focused on the importance of the lipid‐transporting
apolipoproteins–apoB transports all potentially atherogenic very low‐density lipoprotein …